Sanrabine IV infusion 250mg, manufactured by Asahi Kasei Pharma, contains Enocitabine, a chemotherapeutic agent used to treat certain types of cancer, including acute myeloid leukemia (AML). It is an injectable drug with a YJ code of 4224402D3039 and a standard of 250mg 1 bottle.
Sanrabine IV infusion 250mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →